Cleveland, OH-The amount of time that physicians are able to share with patients is in constant jeopardy. For physicians, the added benefit of using shared appointments is a no-brainer. Shared appointments can be more efficient and allow them to see more patients throughout any given day.

Just the idea of shared doctor’s appointments may make some patients cringe out of a lack of privacy, but for our increasingly rushed healthcare professionals, experimenting with new forms of visitation can be a delightful relief. And with an increasing amount of pressure from health insurers to bring down the cost of care while treating the increasing number of people with health insurance, patients should expect experiments such as this to become more prevalent throughout major health systems.


The theory behind this practice is that patients will be able to find greater value in these visits by being able to learn from others’ experiences and that the healthcare professional will be able to have a more relaxed discussion rather than continually jumping from room to room in 8 minute intervals. In addition, these group visits provide a place to leverage the power of social proofs, which have been proven to increase adherence.

These group medical visits have been proven to help diabetics control blood sugar and blood pressure. And the approach has been particularly useful for patients who are managing chronic conditions such as diabetes, asthma, and osteoporosis.


About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.